Lokwani Ravi, Fertil Daphna, Hartigan Devon R, Josyula Aditya, Ngo Tran B, Sadtler Kaitlyn
Section on Immunoengineering, Center for Biomedical Engineering and Technology Acceleration, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.
Adv Healthc Mater. 2025 Feb;14(5):e2400134. doi: 10.1002/adhm.202400134. Epub 2024 Jul 27.
The immune response to decellularized extracellular matrix (ECM) muscle injury is characterized by Th2 T cells, Tregs, M2-like macrophages, and an abundance of eosinophils. Eosinophils have previously been described as mediators of muscle regeneration but inhibit skin wound healing. In addition to response to wounding, a large number of eosinophils respond to biomaterial-treated muscle injury, specifically in response to decellularized ECM. ECM treatment of muscle wounds has been associated with positive outcomes in tissue regeneration, but the detailed mechanisms of action are still being evaluated. Here, this work investigates the role of these eosinophils in terms of their immunologic phenotype and subsequent effect on the local tissue microenvironment. These cells have a mixed phenotype showing both type-2 and regulatory gene upregulation and but are not required for macrophage polarization. Beyond the local tissue, ECM treatment is seen to induce a transient flux of eosinophils to the lungs but prevented a trauma-associated neutrophilia in the lungs of injured mice. This work believes this local and systemic immunomodulation contributes to the regenerative effects of the material and such distal tissue effects should be considered in therapeutic design and implementation.
对脱细胞细胞外基质(ECM)肌肉损伤的免疫反应的特征是Th2 T细胞、调节性T细胞(Tregs)、M2样巨噬细胞和大量嗜酸性粒细胞。嗜酸性粒细胞以前被描述为肌肉再生的介质,但会抑制皮肤伤口愈合。除了对伤口的反应外,大量嗜酸性粒细胞对生物材料处理的肌肉损伤有反应,特别是对脱细胞ECM有反应。ECM处理肌肉伤口与组织再生的积极结果相关,但具体作用机制仍在评估中。在此,这项工作从嗜酸性粒细胞的免疫表型及其对局部组织微环境的后续影响方面研究了这些嗜酸性粒细胞的作用。这些细胞具有混合表型,显示2型和调节基因上调,但不是巨噬细胞极化所必需的。除了局部组织外,还观察到ECM处理会诱导嗜酸性粒细胞短暂流入肺部,但可防止受伤小鼠肺部出现与创伤相关的中性粒细胞增多。这项工作认为这种局部和全身免疫调节有助于材料的再生作用,并且在治疗设计和实施中应考虑这种远端组织效应。